Peter Traber
Direktor/Vorstandsmitglied bei Baylor College of Medicine
Vermögen: 110 791 $ am 30.04.2024
Aktive Positionen von Peter Traber
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Baylor College of Medicine | Direktor/Vorstandsmitglied | 01.01.2008 | - |
Vorstandsvorsitzender | 01.01.2003 | 01.01.2008 |
Karriereverlauf von Peter Traber
Ehemalige bekannte Positionen von Peter Traber
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
CARTESIAN THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 30.03.2020 | 13.11.2023 |
Alacrita Consulting Ltd. | Corporate Officer/Principal | 01.07.2018 | 01.08.2020 |
GALECTIN THERAPEUTICS INC. | Direktor/Vorstandsmitglied | 12.02.2009 | 14.12.2017 |
Vorstandsvorsitzender | 23.03.2011 | 06.07.2018 | |
Technik-/Wissenschafts-/F&E-Leiter | 18.06.2010 | 06.07.2018 | |
Investor Relations Kontakt | 12.02.2009 | - | |
Präsident | 23.03.2011 | 06.07.2018 | |
Tanox, Inc.
Tanox, Inc. Pharmaceuticals: MajorHealth Technology Tanox, Inc engages in the discovery and development of therapeutic monoclonal antibodies in the areas of asthma, allergy, inflammation, other diseases affecting the human immune system, and infectious diseases. Its product, Xolair (omalizumab), is used for treatment of adults and adolescents with moderate-to-severe persistent asthma | Direktor/Vorstandsmitglied | - | 03.08.2007 |
GSK PLC | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2000 | 01.01.2003 |
General Counsel | 01.01.2000 | 01.01.2003 | |
Morphic Therapeutic, Inc.
Morphic Therapeutic, Inc. BiotechnologyHealth Technology Morphic Therapeutic, Inc. engages in biotechnology drug development activity. The company is headquartered in Waltham, MA. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
University of Pennsylvania Medical Center | Corporate Officer/Principal | - | - |
Caladrius Biosciences, Inc.
Caladrius Biosciences, Inc. BiotechnologyHealth Technology Caladrius Biosciences, Inc. is a biopharmaceutical company, which engages in development of cell therapies for select cardiovascular and autoimmune diseases. Its product pipeline includes XOWNA, CLBS12, CLBS201 and CLBS14. The company was founded on September 18, 1980 and is headquartered in Basking Ridge, NJ. | Direktor/Vorstandsmitglied | 22.01.2015 | - |
Independent Dir/Board Member | 22.01.2015 | - | |
░░░ ░░░░░░░░░░ ░░ ░░░░░░░░░░░░ ░░░░░░ ░░░░░░ | ░░░░░░░░░ | - | - |
░░░░░░░░ ░░░ | ░░░░░░░░ | ░░░░░░░░░░ | - |
░░░░░░░░░ | ░░░░░░░░░░ | - | |
░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
Ausbildung von Peter Traber
University of Michigan | Undergraduate Degree |
The Wayne State University School of Medicine | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 13 |
Vereinigtes Königreich | 3 |
Operativ
Director/Board Member | 5 |
Chief Tech/Sci/R&D Officer | 4 |
President | 3 |
Sektoral
Health Technology | 7 |
Consumer Services | 5 |
Producer Manufacturing | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
GALECTIN THERAPEUTICS INC. | Health Technology |
GSK PLC | Health Technology |
Private Unternehmen | 8 |
---|---|
Tanox, Inc.
Tanox, Inc. Pharmaceuticals: MajorHealth Technology Tanox, Inc engages in the discovery and development of therapeutic monoclonal antibodies in the areas of asthma, allergy, inflammation, other diseases affecting the human immune system, and infectious diseases. Its product, Xolair (omalizumab), is used for treatment of adults and adolescents with moderate-to-severe persistent asthma | Health Technology |
Noble International Ltd.
Noble International Ltd. Auto Parts: OEMProducer Manufacturing Noble International Ltd. manufactures and supplies automotive components, provides laser welding and cutting services. The company is headquartered in Troy, MI. | Producer Manufacturing |
Terrasep LLC | |
The University of Pennsylvania Health System
The University of Pennsylvania Health System Miscellaneous Commercial ServicesCommercial Services The University of Pennsylvania Health System provides general patient care as well as medical education and research services. The company was founded in 1874 and is headquartered in Philadelphia, PA. | Commercial Services |
Caladrius Biosciences, Inc.
Caladrius Biosciences, Inc. BiotechnologyHealth Technology Caladrius Biosciences, Inc. is a biopharmaceutical company, which engages in development of cell therapies for select cardiovascular and autoimmune diseases. Its product pipeline includes XOWNA, CLBS12, CLBS201 and CLBS14. The company was founded on September 18, 1980 and is headquartered in Basking Ridge, NJ. | Health Technology |
Selecta Biosciences, Inc.
Selecta Biosciences, Inc. BiotechnologyHealth Technology Selecta Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. Its portfolio includes pipeline, autoimmune, gene therapy, and biologic therapy. The company was founded by Omid C. Farokhzad, Robert S. Langer Jr., and Ulrich von Andrian on December 10, 2007 and is headquartered in Watertown, MA. | Health Technology |
Alacrita Consulting Ltd. | |
Morphic Therapeutic, Inc.
Morphic Therapeutic, Inc. BiotechnologyHealth Technology Morphic Therapeutic, Inc. engages in biotechnology drug development activity. The company is headquartered in Waltham, MA. | Health Technology |
- Börse
- Insiders
- Peter Traber
- Erfahrung